Prognostic significance of loss of heterozygosity on chromosome 9p21–22 in human esophageal cancer
✍ Scribed by Naofumi Ohsawa; Shinya Uchino; Takao Saito; Masaki Miyahara; Tokuji Inoue; Seigo Kitano
- Publisher
- Springer
- Year
- 1997
- Tongue
- English
- Weight
- 525 KB
- Volume
- 2
- Category
- Article
- ISSN
- 1341-9625
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Loss of heterozygosity on chromosome 9 has been reported in a variety of human cancers. The cyclin-dependent kinase inhibitor p16 gene, mapped on chromosome 9p21, is presumed to be the tumor-suppressor gene localized in this chromosome. The aim of our study was to determine, in 26 Barrett's adenocar
Loss of heterozygosity (LOH) studies reported thus far suggest that tumor suppressor loci on chromosome 5q are important in esophageal cancer (EC) while little is known about the involvement of chromosome 5p. To investigate the potential existence of tumor suppressor gene(s) on chromosome 5 contribu
The analysis of loss of heterozygosity (LOH) in tumours can be a powerful tool for mapping the sites of tumour suppressor genes in the human genome. A panel of breast cancer patients was assembled as pairs of tumour and lymphocyte DNA samples and LOH studies carried out by Southern hybridisation wit
Chromosome region 9p21 contains a tumor suppressor locus (p16) that may be involved in the genesis of several kinds of malignant tumors. To characterize the role of this gene in the development of soft-tissue tumors (STTs), we investigated the frequency of loss of heterozygosity (LOH) at this locus.